Navigation Links
Pharmos Corporation Reports 2008 First Quarter Results
Date:5/8/2008

mune disorders. The Company's lead product, dextofisopam, is being studied in a Phase 2b clinical trial in patients with IBS. Dextofisopam has completed a Phase 2a IBS study in which it demonstrated a statistically significant effect compared to placebo on the primary efficacy endpoint of adequate relief (n=141, p=0.033) and was very well tolerated. A second program in Phase 2a involves a clinical trial of our NanoEmulsion cream drug delivery system to deliver the NSAID diclofenac topically in patients suffering from osteoarthritic knee pain. The Company's core proprietary technology platform focuses on discovery and development of synthetic cannabinoid compounds, especially CB2 receptor-selective (CB2-selective) agonists. PRS-639,058, the leading CB2-selective agonist, has demonstrated promising preclinical data in neuropathic pain. Various other CB2-selective compounds from Pharmos' pipeline are in preclinical studies targeting pain, multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease and other disorders.

Safe Harbor Statement

Statements made in this press release related to the business outlook and future financial performance of Pharmos, to the prospective market penetration of its drug products, to the development and commercialization of its pipeline products and to its expectations in connection with any future event, condition, performance or other matter, are forward-looking and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties that may cause results to differ materially from those set forth in these statements. Additional economic, competitive, governmental, technological, marketing and other factors identified in Pharmos' filings with the Securities and Exchange Commission could affect such results.

(Tables attached)

PHARMOS CORPORATION

(Unaudited)

Consolidated Statements
'/>"/>

SOURCE Pharmos Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Pharmos Issues Letter to Shareholders
2. Pharmos Corporation Reports 2007 Third Quarter Results
3. Pharmos Corporation to Present at the 2007 RBC Capital Markets Healthcare Conference
4. Pharmos Corporation Announces President & COO Alan L. Rubino to Leave Company
5. Pharmos Corporation Announces Board and Management Changes
6. Pharmos Corporation Completes Initial Closing of Private Placement
7. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
8. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
9. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. BioElectronics Corporation Announces Singapore and Malaysia Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... at the University of Surrey have discovered how the ... body,s clock genes. , The new study, published today ... this clock activity in turn regulates the cycle of ... also discovered that the local biological clock and its ... of the clock in bladder physiology and ageing. ...
(Date:8/22/2014)... (August 22nd), in the scientific journal PLoS ... establish the effect of serotonin on sensitivity to ... optical techniques., "Serotonin is a small molecule known ... brain functions, from the control of sleep and ... This neurotransmitter is also popularly thought to contribute ...
(Date:8/22/2014)... direct observations of how facets form and develop ... sophisticated and effective nanocrystal design and reveal that ... growth breaks down at the nanoscale. , Researchers ... Berkeley National Laboratory (Berkeley Lab) used highly sophisticated ... camera to capture the physical mechanisms that ...
(Date:8/22/2014)... particles are intensively investigated for application as ... agents and components in photonics and molecular ... fundamental for understanding physical and chemical properties, ... University, USA, have demonstrated that high-resolution electron ... three-dimensional structure in which all gold atoms ...
Breaking Biology Technology:Treatment for overactive bladder and irritable bowel syndrome advanced through pioneering research 2From happiness to pain: Understanding serotonin's function 2Shaping the future of nanocrystals 2Shaping the future of nanocrystals 3Shaping the future of nanocrystals 4A breakthrough in imaging gold nanoparticles to atomic resolution by electron microscopy 2
... Elizabeth P. Roquemore, Sam Murphy, *Stephen ... Swinburne , , ... 9NA England, , ... throughput imaging systems, analysis algorithms and associated,cellular assays have begun to be used ...
... , Key words: ... LC-MS/MS • DeCyder MS • differential analysis, ... was used in conjunction with tandem mass spectrometry (MS/MS) to separate ... tree, Olea europaea . DeCyder™ MS Differential Analysis Software (DeCyder ...
... Karlsson, and H. Lindgren , ... Sweden , , ... columns prepacked with Ni Sepharose 6 Fast Flow without the need for a ... the highest available on the market, and separations can be completed in as ...
Cached Biology Technology:Is Z' factor the best assessment for the quality of cellular assays delivering higher content? 2Is Z' factor the best assessment for the quality of cellular assays delivering higher content? 3Is Z' factor the best assessment for the quality of cellular assays delivering higher content? 4Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 2Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 3Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 4Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 5Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 6Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 7Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 8Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 9New gravity-flow column gives faster and simpler purification of histidine-tagged proteins 2New gravity-flow column gives faster and simpler purification of histidine-tagged proteins 3New gravity-flow column gives faster and simpler purification of histidine-tagged proteins 4
(Date:8/21/2014)... 18-22, 2014 , WHERE: , San Diego ... CA 92101 , WHAT: , Invited and ... latest research in human genetics. Examples of sessions ... on rare genetic variants in health and disease, ... sun sensitivity (Saturday, Oct. 18, 5:30-7:30 pm) , ...
(Date:8/21/2014)... tube connectors, designed by an international standards process, will ... According to an invited review published in the OnlineFirst ... NCP ), the official journal of the American Society ... will greatly reduce the occurrence of misconnection that can ... connectors, which are used to join medical devices, components, ...
(Date:8/21/2014)... has successfully replicated one of the crucial steps in ... sunlight which could manufacture hydrogen as a fuel. , ... an exciting prospect to use them to create hydrogen, ... Hingorani, from the ARC Centre of Excellence for Translational ... Hydrogen offers potential as a zero-carbon replacement for petroleum ...
Breaking Biology News(10 mins):American Society of Human Genetics 2014 Annual Meeting 2New feeding tube connectors will improve patient safety 2Water and sunlight the formula for sustainable fuel 2
... marker for Alzheimer,s disease rises and falls in the spinal ... researchers at Washington University School of Medicine in St. Louis ... young people and reinforces a link between increased Alzheimer,s risk ... The brain,s relative inactivity during sleep may provide an ...
... NEW YORK (Sept. 26, 2011) -- The National Institutes ... Research Project (T-R01) Award to fund research into risk factors ... area of the affected baby,s spine or brain is not ... Margaret Elizabeth Ross and Dr. Christopher E. Mason at Weill ...
... Rochelle, NY, September 26, 2011Magnetic resonance tractography (MRT) ... human brain anatomy and, as MRT methods and ... and illuminating information on brain activity and connectivity. ... this technology is explored in a forward-looking review ...
Cached Biology News:Marker for Alzheimer's disease rises during day and falls with sleep 2Marker for Alzheimer's disease rises during day and falls with sleep 3NIH awards $5.5 million grant to Weill Cornell for research into preventing spina bifida 2NIH awards $5.5 million grant to Weill Cornell for research into preventing spina bifida 3
...
... Endogenous potent vasoconstrictor peptide. Displays selectivity ... vascular tonus. ET-1, ET-2, and ET-3 are ... ET-2 and ET-3 are similar to ET-1, ... acids, respectively. All three isopeptides produce strong ...
HNF-1 Purified Anti-Mouse, Anti-Rat, Anti-Rabbit, Anti-Human clone 2, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
... include subcloning of gene in baculoviral ... isolation and plaque purification of ten ... stock for one clone, protein expression ... cell culture. Expected yield and timeline: ...
Biology Products: